内源性性激素与多部位慢性肌肉骨骼疼痛的关联
基于英国生物银行357 424名参与者的数据,研究探讨性激素及性激素结合球蛋白与慢性肌肉骨骼疼痛的关联。结果显示,较高的睾酮浓度及睾酮/性激素结合球蛋白比值与男女两性较少的慢性疼痛部位数及较低的各部位慢性疼痛风险相关,而雌二醇未见关联。
要点
- 较高的睾酮浓度与男女两性较少的慢性肌肉骨骼疼痛部位数相关。
- 较高的睾酮/性激素结合球蛋白比值与较低的各部位慢性疼痛风险相关。
- 较高的性激素结合球蛋白浓度与较低的颈/肩部慢性疼痛风险相关。
核心结论
- 在男女两性中,较高的睾酮浓度和睾酮/性激素结合球蛋白比值与较少的慢性肌肉骨骼疼痛部位数及较低的各部位慢性疼痛风险相关。
- 较高的性激素结合球蛋白浓度与较低的颈/肩部慢性疼痛风险相关。
- 雌二醇浓度及雌二醇/性激素结合球蛋白比值与慢性疼痛部位数或各部位慢性疼痛无关联。
研究设计与样本
- 研究利用英国生物银行数据,共纳入357 424名参与者,女性占51.6%,白人占95.2%。
- 基线测量血清雌二醇、睾酮和性激素结合球蛋白浓度,并在基线和三次随访中评估颈部/肩部、背部、髋部、膝部或全身的慢性疼痛(≥3个月)。
- 采用混合效应多项/逻辑回归模型进行分析。
主要发现
- 在多变量分析中,男性睾酮每增加一个标准差,慢性肌肉骨骼疼痛部位数的相对风险比为0.81(95%CI 0.77-0.86),睾酮/性激素结合球蛋白为0.85(95%CI 0.80-0.92)。
- 女性睾酮每增加一个标准差,慢性肌肉骨骼疼痛部位数的相对风险比为0.85(95%CI 0.81-0.89),睾酮/性激素结合球蛋白为0.93(95%CI 0.89-0.97),所有趋势P值≤0.001。
- 较高的睾酮浓度和睾酮/性激素结合球蛋白与所有部位慢性疼痛的较低风险相关。
- 较高的性激素结合球蛋白浓度与男女两性颈/肩部慢性疼痛的较低风险相关。
- 雌二醇、性激素结合球蛋白或雌二醇/性激素结合球蛋白与慢性疼痛部位数或各部位慢性疼痛无关联。
临床怎么用
- 临床中可关注男性与女性慢性肌肉骨骼疼痛患者的睾酮水平及睾酮/性激素结合球蛋白比值,但其因果关系及干预价值尚需进一步研究。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sex-differences in pain perception have been documented; however, the role of sex hormones in chronic musculoskeletal pain (CMP) remains unclear. Therefore, this study investigated whether sex hormones and sex hormone-binding globulin (SHBG) are associated with CMP. METHODS: We utilised data from the UK Biobank (n=357 424; females: 51.6%; white: 95.2%). Serum concentrations of oestradiol (E2), testosterone (T), and SHBG were measured at baseline. Chronic pain (≥3 months) in the neck/shoulder, back, hip, knee, or 'all over the body' was assessed at baseline and three follow-ups. Mixed-effects multinomial/logistic regression models were used. RESULTS: In multivariable analyses, greater concentrations of T and T/SHBG were associated with a lower number of CMP sites in both males (T: relative risk ratio=0.81 per standard deviation, 95% confidence interval [0.77-0.86] and T/SHBG: 0.85 [0.80-0.92]) and females (T: 0.85 [0.81-0.89] and T/SHBG: 0.93 [0.89-0.97] [all P-values for trend ≤0.001]). Greater T concentrations and T/SHBG were also associated with lower odds of CMP across all sites, while higher concentrations of SHBG were associated with lower odds of neck/shoulder CMP in both sexes. There was no association between concentrations of E2, SHBG, or E2/SHBG and number of CMP or site-specific CMP in either sex. CONCLUSION: In both sexes, greater T concentrations and T/SHBG were associated with lower number of CMP sites and site-specific CMP, while greater concentrations of SHBG were linked to lower odds of neck/shoulder CMP. These findings suggest a potential involvement of sex steroids in the pathogenesis of CMP and underscore the need for further investigation into their potential in chronic pain management strategies.
引用
- Kifle ZD, Tian J, Aitken D, et al. Associations between endogenous sex hormones and multisite chronic musculoskeletal pain. Br J Anaesth. 2024. PMID: 39706703. doi:10.1016/j.bja.2024.11.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。